Investigating Non-sterilizing Cure in TB Patients at the End of Successful Anti-TB Therapy

Mycobacterium tuberculosis (Mtb) is extremely recalcitrant to antimicrobial chemotherapy requiring 6 months to treat drug-sensitive tuberculosis (TB). Despite this, 4–10% of cured patients will develop recurrent disease within 12 months after completing therapy. Reasons for relapse in cured TB patie...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Cell Infect Microbiol
Autors principals: Beltran, Caroline G. G., Heunis, Tiaan, Gallant, James, Venter, Rouxjeane, du Plessis, Nelita, Loxton, Andre G., Trost, Matthias, Winter, Jill, Malherbe, Stephanus T., Kana, Bavesh D., Walzl, Gerhard
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Cellular and Infection Microbiology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7477326/
https://ncbi.nlm.nih.gov/pubmed/32984071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcimb.2020.00443
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars